PATENTS & PUBLICATIONS
PATENTS
Method and device for producing lipid vesicles
granted by: AU 2002215987; CA 2,427,640; EP 1337322; US 6,843,942
Application of superoxide dismutase in liposomes
granted by: AU 690377; CA 2,204,493; EP 0789584; MX 206295; NZ 296098; US 5,942,245; US 6,312,720
Superloaded liposomes for drug delivery
granted by: AU 2005247091; CA 2,567,961; CN 1960706A; EA 200602172; EP 1748760; IN 244478; KR 1212377
Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition
granted by: AU 04024753.8; CA 2,583,332; EA 011391; EP 1802277; JP 5688199; KR 1289917; NZ 554183; US 8,524,274
SELECTED PUBLICATIONS
Bonduelle O, Chaudesaigues C, Tolazzi M, Suleiman E, de Bernard S, Alves K, Nourikyan J, Bohec M, Baudrin LG, Katinger D, Debré P, Scarlatti G, Vieillard V, Combadière B (2022) Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast with Aluminum Hydroxide Formulation. Front. Immunol. 13
Suleiman E, Mayer J, Lehner E, Kohlhauser B, Katholnig A, Batzoni M, Damm D, Temchura V, Wagner A, Überla K, Vorauer-Uhl K (2020) Conjugation of Native-Like HIV-1 Envelope Trimers onto Liposomes Using EDC/Sulfo-NHS Chemistry: Requirements and Limitations. Pharmaceutics 12(10), 979
Suleiman E, Damm D, Batzoni M, Temchura V, Wagner A, Überla K, Vorauer-Uhl K (2019) Electrostatically Driven Encapsulation of Hydrophilic, Non-Conformational Peptide Epitopes into Liposomes. Pharmaceutics 11(11), 619
Bolger GT, Licollari A, Bagshaw R, Tan A, Greil R, Vcelar B, Majeed M, Sordillo P (2019) Intense Uptake of Liposomal Curcumin by Multiple Myeloma Cell Lines: Comparison to Normal Lymphocytes, Red Blood Cells and Chronic Lymphocytic Leukemia Cells. Anticancer Res 39(3):1161-1168
Bolger GT, Licollari A, Tan A, Greil R, Vcelar B, Greil-Ressler S, Weiss L, Schönlieb C, Magnes T, Radl B, Majeed M, Sordillo PP (2019) Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals. Cancer Chemother Pharmacol 83(2):265-275
Greil R, Greil-Ressler S, Weiss L, Schönlieb C, Magnes T, Radl B, Bolger GT, Vcelar B, Sordillo PP (2018) A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer. Cancer Chemother Pharmacol 82(4):695-706
Bolger GT, Licollari A, Tan A, Greil R, Pleyer L, Vcelar B, Majeed M, Sordillo P (2018) Distribution of Curcumin and THC in Peripheral Blood Mononuclear Cells Isolated from Healthy Individuals and Patients with Chronic Lymphocytic Leukemia. Anticancer Res 38(1):121-130
Bolger GT, Licollari A, Tan A, Greil R, Vcelar B, Majeed M, Helson L (2017) Distribution and Metabolism of Lipocurc™ (Liposomal Curcumin) in Dog and Human Blood Cells: Species Selectivity and Pharmacokinetic Relevance. Anticancer Res 37(7):3483-3492
Kloesch B, Gober L, Loebsch S, Vcelar B, Helson L, Steiner G (2016) In Vitro Study of a Liposomal Curcumin Formulation (Lipocurc™): Toxicity and Biological Activity in Synovial Fibroblasts and Macrophages. In Vivo 30(4):413-9
Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Bolger G, Helson L, Wolzt M (2015) Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharmacol Ther 53(1):54-65
Koutsoulas C, Suleiman E, Wagner A, Žabka M (2014) Comparative study between synthetic and phospholipids of natural origin: effect of phospholipid selection on the behaviour of a topical liposomal dosage form incorporating terbinafie. J Liposome Res 24(4):336-43
Rodrigueza WV, Woolliscroft MJ, Ebrahim AS, Forgey R, McGovren PJ, Endert G, Wagner A, Holewa D, Aboukameel A, Gill RD, Bisgaier CL, Messmann RA, Whitehead CE, Izbicka E, Streeper R, Wick MC, Stiegler G, Stein CA, Monsma D, Webb C, Sooch MP, Panzner S, Mohammad R, Goodwin NC, Al-Katib A (2014) Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide. Cancer Chemother Pharmacol 74(1):151-66
Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, Helson L, Wolzt M (2013) Effect of liposomal curcumin on red blood cells in vitro. Anticancer Res 33(9):3629-34
Katinger D, Wagner A, Luque I, Crespillo S, Conejero-Lara F, Roger M, Martin C, Mouz N, Mourao S, Farsang A, Notka F, Malcolm K, Bosquet N, Le Grand R, Moog C, Cope A, Shattock R, Lewis DJ, El Habib R (2012) Liposomal formulation of Gp41 derivate with adjuvant MPLA: vaccine design, immunogenicity in animals and safety in humans. Retrovirology 9 (Suppl 2):354
Birnbaumer G, Küpcü S, Jungreuthmayer C, Richter L, Vorauer-Uhl K, Wagner A, Valenta C, Sleytr U, Ertl P (2011) Rapid liposome quality assessment using a lab-on-a-chip. Lab Chip. 11(16):2753-62
Wagner A, Vorauer-Uhl K (2011) Liposome Technology for Industrial Purposes. Journal of Drug Delivery 2011, 9 pages
Wagner A, Stiegler G, Vorauer-Uhl K, Katinger H, Quendler H, Hinz A, Weissenhorn W (2007) One Step Membrane Incorporation of Viral Antigens as a Vaccine Candidate Against HIV. J Liposome Res 17(3):139-54
Wagner A, Platzgummer M, Kreismayr G, Quendler H, Stiegler G, Ferko B, Vecera G, Vorauer-Uhl K, Katinger H (2006) GMP Production of Liposomes-A New Industrial Approach. J Liposome Res 16(3):311-9
Vorauer-Uhl K, Wagner A, Borth N, Katinger H (2002) Long term stability of rh-Cu/Zn-SOD-liposomes prepared by the crossflow injection technique following ICH-guidelines. European Journal of Pharmaceutics and Biopharmaceutics 54:77-81
Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H (2002) Enhanced protein loading into liposomes by the multiple injection technique. Journal of Liposome Research 12(3):271-83
Wagner A, Vorauer-Uhl K, Kreismayr G, Katinger H (2002) The crossflow injection technique - an improvement of the ethanol injection method. Journal of Liposome Research 12(3):259-70
Wagner A, Vorauer-Uhl K, Katinger H (2002) Liposome produced in a pilot scale: production, purification and efficiency aspects. European Journal of Pharmaceutics and Biopharmaceutics 54:213-9
MEET US AT
CRS Germany, Bad Dürkheim, Germany, February 29 - March 1, 2024
Daniel Kumar, Thomas Vrucina
European Symposion on Controlled Drug Delivery, Egmond aan Zee, Netherlands, April 10-12, 2024
Dr. Andreas Wagner
TIDES USA, Boston, USA, May 14-17, 2024
Thomas Vrucina, Dr. Andreas Wagner
Applied Biophysics Forum
in Drug Delivery, Copgenhagen, Denmark, May 27-28, 2024
Dr. Andreas Wagner
Levitronix Bioprocessing Conference, Cambridge MA, USA, June 20, 2024
Dr. Andreas Wagner
Liposome Research Days, Glasgow, UK, June 26-29, 2024
Thomas Vrucina, Dr. Andreas Wagner
mRNA Health, Boston, USA, November 12-14, 2024
Thomas Vrucina, Dr. Andreas Wagner